Science Explorer Interactive view Map
Company · New Haven · United States

Arvinas (United States)

arvinas.comROR OpenAlex
Research works
82
▲ 14% vs 2013–17
Citations
6.5k
79.0 per fractional work
Top-10% rate
33.5%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: Arvinas (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.12× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.77× its world share, 15 worksBiochemistry, Geneti…Immunology and Microbiology: 0.92× its world share, 0 worksImmunology and Micro…Neuroscience: 0.09× its world share, 0 worksNeuroscienceChemistry: 0.97× its world share, 0 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEnergy: 0.77× its world share, 0 worksEnergyEngineering: 0.05× its world share, 0 worksEngineeringHealth Professions: 0.03× its world share, 0 worksHealth ProfessionsMedicine: 2.57× its world share, 17 worksMedicineBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.41× its world share, 0 worksEconomics, Econometr…Psychology: 0.62× its world share, 1 worksPsychologySocial Sciences: 0.10× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.8×. Every wedge is a field page.

Who are the top researchers at Arvinas (United States)?

Ranked on the composite score, Kevin Coleman lead among researchers whose main affiliation is Arvinas (United States).

  1. 1 Kevin Coleman United States · #789,970 worldwide 40 citations · 17 works
All ranked researchers at Arvinas (United States)

Which keywords describe research at Arvinas (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Transcriptional Regulation, BET Bromodomains, PROTACs, Cancer Therapy, PET Imaging, Fibroblast Activation Protein, Tumor Microenvironment and Breast Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 28 words, with their numbers
  1. Transcriptional Regulation8▲ 150×2 topics
  2. BET Bromodomains8▲ 839×1 topic
  3. PROTACs8▲ 839×1 topic
  4. Cancer Therapy8▲ 39×4 topics
  5. PET Imaging6▲ 101×3 topics
  6. Fibroblast Activation Protein5▲ 333×1 topic
  7. Tumor Microenvironment5▲ 33×1 topic
  8. Breast Cancer5▲ 56×4 topics
  9. Immunotherapy4▲ 16×4 topics
  10. Chemotherapy3▲ 12×2 topics
  11. HER22▲ 253×1 topic
  12. Trastuzumab2▲ 159×1 topic
  13. Proteasome Inhibitors2▲ 95×2 topics
  14. Lymphoma2▲ 38×2 topics
  15. Metastatic Breast Cancer2▲ 104×2 topics
  16. Cell Cycle Control2▲ 190×2 topics
  17. Genetic Mutations2▲ 13×4 topics
  18. CDK4/6 Inhibitors2▲ 220×1 topic
  19. Palbociclib2▲ 220×1 topic
  20. CAR T Cells2▲ 70×1 topic
  21. Chimeric Antigen Receptor2▲ 70×1 topic
  22. Proteasome2▲ 133×1 topic
  23. Staging System2▲ 76×2 topics
  24. Ubiquitin2▲ 133×1 topic
  25. Clinical Trials1▲ 5.7×5 topics
  26. Biomarkers1▲ 5.2×2 topics
  27. Gene Expression1▲ 5.6×4 topics
  28. Prostate Cancer1▲ 23×2 topics

Which research topics does Arvinas (United States) publish most on?

By volume in 2022–2025: Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, HER2/EGFR in Cancer Research and Advanced Breast Cancer Therapies.

Protein Degradation and …8Protein Degradation and Inhibitors: 8 fractional worksPeptidase Inhibition and…5Peptidase Inhibition and Analysis: 5 fractional worksHER2/EGFR in Cancer Research: 2 fractional worksAdvanced Breast Cancer Therapies: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksUbiquitin and proteasome pathways: 2 fractional worksHistone Deacetylase Inhibitors Research: 1 fractional worksProstate Cancer Treatment and Research: 1 fractional worksNeuroblastoma Research and Treatments: 1 fractional worksMultiple Myeloma Research and Treatments: 1 fractional works
Molecular BiologyOncologyPulmonary and Respiratory MedicineNeurology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Degradation and Inhibitors Molecular Biology 8 works
  2. 2 Peptidase Inhibition and Analysis Oncology 5 works
  3. 3 HER2/EGFR in Cancer Research Oncology 2 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  5. 5 CAR-T cell therapy research Oncology 2 works
  6. 6 Ubiquitin and proteasome pathways Molecular Biology 2 works
  7. 7 Histone Deacetylase Inhibitors Research Molecular Biology 1 works
  8. 8 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  9. 9 Neuroblastoma Research and Treatments Neurology 1 works
  10. 10 Multiple Myeloma Research and Treatments Hematology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.6%not open58.4%

World: 28% of research is openly available.

with international co-authors19.6%domestic only80.4%

World: 19% is written across borders.

How has Arvinas (United States)'s research output changed?

Output in 2018–2022 was 14% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New Haven

All research institutions in New Haven

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.